Bipolar Percutaneous Endocardial Septal Radiofrequency Ablation (Bi-PESA): First-in-Human Application for

Aiju Tian1, Yuhe Jia1, Minghu Xiao2

  • 1Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

JACC. Case Reports
|December 3, 2025
PubMed
Summary

Combined bipolar and percutaneous endocardial septal radiofrequency ablation (Bi-PESA) offers a new treatment for drug-refractory hypertrophic obstructive cardiomyopathy (HOCM). This novel approach effectively reduced the left ventricular outflow tract gradient and improved patient symptoms.